Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 patients

Santosh George, Anasuya Chattopadhyay Pal, Jacqueline Gagnon, Sushma Timalsina, Pallavi Singh, Pratap Vydyam, Muhammad Munshi, Joy E. Chiu, Isaline Renard, Christina A. Harden, Isabel M. Ott, Anne E. Watkins, Chantal B.F. Vogels, Peiwen Lu, Maria Tokuyama, Arvind Venkataraman, Arnau Casanovas-Massana, Anne L. Wyllie, Veena Rao, Melissa Campbell, Shelli F. Farhadian, Nathan D. Grubaugh, Charles S. Dela Cruz, Albert I. Ko, ‘Yale IMPACT study’ team, Amalia Berna Perez, Elikplim H. Akaho, Dennis G Moledina, Jeffrey Testani, Audrey R John, Michel Ledizet, Choukri Ben Mamoun
doi: https://doi.org/10.1101/2021.01.27.21250637
Santosh George
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anasuya Chattopadhyay Pal
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline Gagnon
2L2 Diagnostics, LLC, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sushma Timalsina
2L2 Diagnostics, LLC, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pallavi Singh
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pratap Vydyam
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad Munshi
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joy E. Chiu
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isaline Renard
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina A. Harden
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel M. Ott
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne E. Watkins
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal B.F. Vogels
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peiwen Lu
6Department of Immunology, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Tokuyama
6Department of Immunology, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arvind Venkataraman
6Department of Immunology, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnau Casanovas-Massana
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne L. Wyllie
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veena Rao
8Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Campbell
4Department of Pediatrics, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelli F. Farhadian
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan D. Grubaugh
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles S. Dela Cruz
10Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert I. Ko
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amalia Berna Perez
9Department of Pediatrics, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Children’s Hospital of Philadelphia, Philadelphia PA 190104 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elikplim H. Akaho
9Department of Pediatrics, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Children’s Hospital of Philadelphia, Philadelphia PA 190104 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis G Moledina
7Department of Internal Medicine, Section of Nephrology and Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, Connecticut, CT 06520 US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Testani
8Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey R John
9Department of Pediatrics, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Children’s Hospital of Philadelphia, Philadelphia PA 190104 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Ledizet
2L2 Diagnostics, LLC, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Choukri Ben Mamoun
1Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, CT 06520 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: choukri.benmamoun{at}yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

SARS-CoV-2 infection has so far affected over 42 million people worldwide, causing over 1.1 million deaths. With the large majority of SARS-CoV-2 infected individuals being asymptomatic, major concerns have been raised about possible long-term consequences of the infection. We developed an antigen capture assay to detect SARS-CoV-2 spike protein in urine samples from COVID-19 patients whose diagnosis was confirmed by PCR from nasopharyngeal swabs (NP-PCR+). The study used a collection of 233 urine samples from 132 participants from Yale New Haven Hospital and the Children’s Hospital of Philadelphia obtained during the pandemic (106 NP-PCR+ and 26 NP-PCR-) as well as a collection of 20 urine samples from 20 individuals collected before the pandemic. Our analysis identified 23 out of 91 (25%) NP-PCR+ adult participants with SARS-CoV-2 spike S1 protein in urine (Ur-S+). Interestingly, although all NP-PCR+ children were Ur-S-, 1 NP-PCR-child was found to be positive for spike protein in urine. Of the 23 Ur-S+ adults, only 1 individual showed detectable viral RNA in urine. Our analysis further showed that 24% and 21% of NP-PCR+ adults have high levels of albumin and cystatin C in urine, respectively. Among individuals with albuminuria (>0.3 mg/mg of creatinine) statistical correlation could be found between albumin and spike protein in urine. Together, our data showe that 1 of 4 of SARS-CoV-2 infected individuals develop renal abnormalities such as albuminuria. Awareness about the long-term impact of these findings is warranted.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

CBM research is supported by grants from National Institute of Health (NIH) and the Steven and Alexandra Cohen Foundation. ARJ is an Investigator in the Pathogenesis of Infectious Diseases of the Burroughs Wellcome Fund, whose work is supported by NIH/NIAID R01AI103280, R21AI144472, and R21AI154370. JMT research was supported by NIH awards (K23HL114868, L30HL115790, R01HL139629, R21HL143092, R01HL128973, R01HL148354). IMPACT received support from the Yale COVID-19 Research Resource Fund. The authors declare no competing financial interests.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by Yale Human Research Protection Program Institutional Review Boards (FWA00002571 protocol ID 2000027690). Urine collection from COVID-19 positive and negative children was conducted under protocol IRB20-017503 approved by the Institutional Review Board at Childrens Hospital of Philadelphia (FWA00000459). Informed consent was obtained from all enrolled participants. The pre-COVID-19 urine samples, from Kidney Biopsy participants were provided by Yale BioBank and the study was approved by Yale Human Investigation Committee (number 11110009286). The pre-COVID-19 urine samples from Heart Failure Cohort and healthy individuals were provided by JMT (HIC 1311013065).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data available upon request.

  • Abbreviations

    NP
    Nasopharyngeal
    ELISA
    Enzyme Linked Immunosorbent Assay
    HCoV
    Human Coronavirus
    KB
    Kidney Biopsy
    AKI
    Acute Kidney Infection
    UELISA
    Urine Capture ELISA
    FENa
    Fractional Excretion of Sodium
    FEUrea
    Fractional excretion of Urea
    Ur-S+
    Urine Spike positive
    Ur-S-
    Urine Spike negative
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted January 31, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 patients
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 patients
    Santosh George, Anasuya Chattopadhyay Pal, Jacqueline Gagnon, Sushma Timalsina, Pallavi Singh, Pratap Vydyam, Muhammad Munshi, Joy E. Chiu, Isaline Renard, Christina A. Harden, Isabel M. Ott, Anne E. Watkins, Chantal B.F. Vogels, Peiwen Lu, Maria Tokuyama, Arvind Venkataraman, Arnau Casanovas-Massana, Anne L. Wyllie, Veena Rao, Melissa Campbell, Shelli F. Farhadian, Nathan D. Grubaugh, Charles S. Dela Cruz, Albert I. Ko, ‘Yale IMPACT study’ team, Amalia Berna Perez, Elikplim H. Akaho, Dennis G Moledina, Jeffrey Testani, Audrey R John, Michel Ledizet, Choukri Ben Mamoun
    medRxiv 2021.01.27.21250637; doi: https://doi.org/10.1101/2021.01.27.21250637
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 patients
    Santosh George, Anasuya Chattopadhyay Pal, Jacqueline Gagnon, Sushma Timalsina, Pallavi Singh, Pratap Vydyam, Muhammad Munshi, Joy E. Chiu, Isaline Renard, Christina A. Harden, Isabel M. Ott, Anne E. Watkins, Chantal B.F. Vogels, Peiwen Lu, Maria Tokuyama, Arvind Venkataraman, Arnau Casanovas-Massana, Anne L. Wyllie, Veena Rao, Melissa Campbell, Shelli F. Farhadian, Nathan D. Grubaugh, Charles S. Dela Cruz, Albert I. Ko, ‘Yale IMPACT study’ team, Amalia Berna Perez, Elikplim H. Akaho, Dennis G Moledina, Jeffrey Testani, Audrey R John, Michel Ledizet, Choukri Ben Mamoun
    medRxiv 2021.01.27.21250637; doi: https://doi.org/10.1101/2021.01.27.21250637

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (434)
    • Allergy and Immunology (760)
    • Anesthesia (222)
    • Cardiovascular Medicine (3316)
    • Dentistry and Oral Medicine (366)
    • Dermatology (282)
    • Emergency Medicine (480)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
    • Epidemiology (13403)
    • Forensic Medicine (19)
    • Gastroenterology (900)
    • Genetic and Genomic Medicine (5182)
    • Geriatric Medicine (483)
    • Health Economics (786)
    • Health Informatics (3286)
    • Health Policy (1146)
    • Health Systems and Quality Improvement (1199)
    • Hematology (432)
    • HIV/AIDS (1024)
    • Infectious Diseases (except HIV/AIDS) (14657)
    • Intensive Care and Critical Care Medicine (917)
    • Medical Education (478)
    • Medical Ethics (128)
    • Nephrology (526)
    • Neurology (4957)
    • Nursing (263)
    • Nutrition (735)
    • Obstetrics and Gynecology (889)
    • Occupational and Environmental Health (797)
    • Oncology (2531)
    • Ophthalmology (730)
    • Orthopedics (284)
    • Otolaryngology (348)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (547)
    • Pediatrics (1308)
    • Pharmacology and Therapeutics (552)
    • Primary Care Research (559)
    • Psychiatry and Clinical Psychology (4225)
    • Public and Global Health (7526)
    • Radiology and Imaging (1717)
    • Rehabilitation Medicine and Physical Therapy (1022)
    • Respiratory Medicine (982)
    • Rheumatology (480)
    • Sexual and Reproductive Health (500)
    • Sports Medicine (425)
    • Surgery (551)
    • Toxicology (73)
    • Transplantation (237)
    • Urology (206)